Internal Medicine, Endocrinology, Diabetes, & Metabolism · Falls Church, VA
NPI
1639426497
Since 2012
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
103 W Broad St Ste 120
Falls Church, VA, 22046
Phone (703) 534-6002
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
450 services
Medicare patients, 2024
164
Average age 75
Drug cost, 2024
$1.4M
1,404 prescriptions
Company payments, 2025
$490
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Miriam H Ahmad was code 99214 (office e&m - established), 303 times for 141 patients. In total Miriam H Ahmad billed 450 services in 11 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 303 | 141 | $100.17 | $30K |
| 95251 Test - Miscellaneous | Office | 79 | 28 | $27.99 | $2,211 |
| 99204 Office E&M - New | Office | 17 | 17 | $136.69 | $2,324 |
| 99213 Office E&M - Established | Office | 15 | 13 | $62.53 | $938 |
| 99215 Office E&M - Established | Office | 15 | 13 | $136.59 | $2,049 |
By year: 2022 $55K for 599 services; 2023 $45K for 507 services; 2024 $39K for 450 services.
Medicare prescription drug claims, 2024
In 2024, the drug Miriam H Ahmad prescribed most often to Medicare patients was Levothyroxine Sodium, with 162 prescriptions and refills. In total Miriam H Ahmad wrote 1,404 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 162 | 441 | 49 | $2,794 |
| Metformin Hcl Generic | 120 | 359 | 40 | $1,077 |
| Jardiance Empagliflozin | 80 | 192 | 23 | $103K |
| Ozempic Semaglutide | 63 | 112 | 15 | $98K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 59 | 154 | 22 | $9,824 |
| Januvia Sitagliptin Phosphate | 58 | 142 | 17 | $70K |
| Alendronate Sodium Generic | 53 | 142 | 15 | $656 |
| Synthroid Levothyroxine Sodium | 47 | 139 | 13 | $4,604 |
| Atorvastatin Calcium Generic | 42 | 126 | 13 | $605 |
| Novolog Flexpen Insulin Aspart | 40 | 101 | 18 | $9,891 |
| Humalog Kwikpen U-100 Insulin Lispro | 35 | 97 | 14 | $10K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 33 | 90 | 15 | $4,958 |
| Tresiba Flextouch U-100 Insulin Degludec | 32 | 99 | 13 | $27K |
| Mounjaro Tirzepatide | 32 | 34 | Under 11 | $35K |
| Glimepiride Generic | 32 | 93 | 12 | $308 |
Brand drugs: 694 claims; generic drugs: 601 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Miriam H Ahmad $490 ($490 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novo Nordisk Inc with $74.43.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 3 | $74.43 |
| Beta Bionics, Inc. BBNX | 2 | $51.06 |
| Amgen Inc. AMGN | 2 | $47.13 |
| Sequel Med Tech, LLC | 2 | $43.53 |
| Lilly USA, LLC LLY | 2 | $41.33 |
| Corcept Therapeutics CORT | 2 | $36.54 |
| Ascensia Diabetes Care Us Inc. | 1 | $35.72 |
| Antares Pharma, Inc. | 1 | $32.62 |
| Dexcom, Inc. DXCM | 1 | $26.48 |
| Insulet Corporation PODD | 1 | $23.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.